NCT05643027View on ClinicalTrials.gov

A Novel Intervention for Patients With Cancer

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 10, 2025

Study Completion Date

June 7, 2026

Conditions
Substance UseCancerPsychological
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

Six-session, skills-based behavioral intervention targeting risk factors for opioid use disorder in the context of cancer

Trial Locations (1)

02215

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER